P. Bode
Delft University of Technology
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by P. Bode.
Toxicology and Industrial Health | 2002
Jorge Gómez-Aracena; Jose M. Martin-Moreno; R.A. Riemersma; P. Bode; Mario Gutiérrez-Bedmar; L. Gorgojo; Jeremy D. Kark; Antonio García-Rodríguez; Enrique Gómez-Gracia; A.F.M. Kardinaal; Antti Aro; P. van 't Veer; H. Wedel; F.J. Kok; Joaquín Fernández-Crehuet
The association between scandium status and risk of acute myocardial infarction (MI) was examined in a multicentre case control study in 10 centres from Europe and Israel. Scandium in toenails was assessed in 684 cases and 724 controls less than 70 years of age. Mean concentrations of toenail scandium were 6.74 micro/kg in cases and 7.75 microg/kg in controls. Scandium among controls, adjusted for age and centre was positively associated with concentrations of lycopene and oleic acid in adipose tissue (P = 0.002 for both nutrients). Pearson correlations adjusted for age and centre were significant (P < 0.05) between scandium and lycopene (r = 0.08), zinc (r = 0.08), mercury (r = 0.18) and oleic acid (r = 0.21). Overall, cases had lower levels of scandium than controls after adjustment for age and centre (case control ratio, 0.87; 95% CI 0.79-0.96). This association persisted after adjustment for other cardiovascular risk factors (case-control ratio 0.88; 95% CI, 0.79-0.98). The risk of MI at high scandium levels was reduced after adjustment for age and centre (P-trend = 0.04). Further adjustments for BMI, history of hypertension, smoking, alcohol intake, diabetes, family history of CHD, alpha-tocopherol, beta-carotene, lycopene, selenium and mercury slightly attenuated this trend (P = 0.055). Our results suggest that toenail scandium level is associated with a reduced risk of acute MI, but we are uncertain whether this element can really play a protective role in the development of CHD. Without an identified plausible mechanism, these results should be regarded as preliminary and should be tested in future studies.
Cancer Epidemiology, Biomarkers & Prevention | 2003
Piet A. van den Brandt; Maurice P. Zeegers; P. Bode; R. Alexandra Goldbohm
Cancer Research | 1993
P.A. van den Brandt; P. van 't Veer; R.A. Goldbohm; P. Bode; E. Dorant; R.J.J. Hermus; F. Sturmans
American Journal of Epidemiology | 1994
P.A. van den Brandt; R.A. Goldbohm; P. van 't Veer; P. Bode; E. Dorant; R.J.J. Hermus; F. Sturmans
Cancer Epidemiology, Biomarkers & Prevention | 2002
Maurice P. Zeegers; R. Alexandra Goldbohm; P. Bode; Piet A. van den Brandt
Cancer Epidemiology, Biomarkers & Prevention | 1993
P.A. van den Brandt; R.A. Goldbohm; P. van 't Veer; P. Bode; R.J.J. Hermus; F. Sturmans
Cancer Epidemiology and Prevention Biomarkers | 2003
Piet A. van den Brandt; Maurice P. Zeegers; P. Bode; R. Alexandra Goldbohm
American Journal of Epidemiology | 1993
P.A. van den Brandt; R.A. Goldbohm; P. van 't Veer; P. Bode; E. Dorant; R.J.J. Hermus; F. Sturmans
TSG: Tijdschrift voor sociale gezondheidszorg, 3, 71, 22 | 1993
P.A. van den Brandt; R.A. Bausch-Goldbohm; P. van 't Veer; P. Bode; E. Dorant; R.J.J. Hermus; F. Sturmans
Food and Chemical Toxicology | 1993
Piet A. van den Brandt; R. Alexandra Goldbohm; P. vantVeer; P. Bode; E. Dorant